Myfortic Tablet 180mg

₨ 12,580

In stock
FormulaMycophenolic Acid (180mg)
Pack size120's
FormTablet
Delivery in 2 to 3 working daysTo cities across Pakistan, delivery from ₨ 300
Cash on deliveryOr pay by bank transfer or card at checkout
Genuine productsFrom a DRAP-licensed pharmacy
Damaged or wrong item?We take it back. Read the return policy
Have a prescription? Upload it and our pharmacist will check your order.Questions about this product? WhatsApp 0336 3300001

About this product

Overview

Myfortic Tablet 180mg contains the active ingredient mycophenolic acid, which is the active metabolite of mycophenolate sodium. It is a medication used to prevent organ rejection in people who have received kidney transplants. Mycophenolic acid belongs to a class of drugs known as immunosuppressants, which work by suppressing the immune system to prevent it from attacking transplanted organs.

Active Ingredient

  • Mycophenolic Acid: Mycophenolic acid inhibits the enzyme inosine monophosphate dehydrogenase (IMPDH), which is involved in the de novo synthesis of guanosine nucleotides in T and B lymphocytes. By blocking this pathway, mycophenolic acid prevents the proliferation of lymphocytes, particularly T-lymphocytes, and inhibits the production of antibodies by B-lymphocytes. This immunosuppressive effect helps to prevent rejection of transplanted organs.

Mechanism of Action

Mycophenolic acid exerts its immunosuppressive effects by selectively inhibiting the activity of inosine monophosphate dehydrogenase (IMPDH), an enzyme involved in the de novo synthesis of guanosine nucleotides. By blocking this pathway, mycophenolic acid suppresses the proliferation of T and B lymphocytes and inhibits the production of antibodies by B-lymphocytes. This leads to a reduction in the immune response and helps prevent rejection of transplanted organs.

Uses

Myfortic Tablet 180mg is indicated for:

  1. Prophylaxis of organ rejection in adult patients receiving kidney transplants in combination with other immunosuppressive agents.
  2. Reduction of the risk of acute rejection in pediatric patients older than 5 years of age who have received kidney transplants.

Dosage and Administration

The dosage of Myfortic Tablet 180mg varies depending on factors such as the patient’s weight, renal function, and concomitant medications. It is usually administered orally, preferably on an empty stomach, at least 1 hour before or 2 hours after meals. The tablets should be swallowed whole with water and should not be crushed, chewed, or broken.

Side Effects

Common side effects associated with Myfortic Tablet 180mg may include:

  • Diarrhea
  • Nausea
  • Vomiting
  • Abdominal pain
  • Headache
  • Hypertension
  • Urinary tract infection
  • Leukopenia (reduced white blood cell count)
  • Anemia
  • Increased susceptibility to infections

Precautions

  • Myfortic Tablet 180mg should be used with caution in patients with gastrointestinal disorders, hepatic impairment, or renal dysfunction.
  • Patients taking mycophenolic acid should undergo regular monitoring of renal function, blood cell counts, and liver enzymes to detect and manage potential adverse effects.
  • Mycophenolic acid is contraindicated during pregnancy due to its teratogenic effects and should be avoided in women of childbearing potential unless adequate contraception is used.

Myfortic Tablet 180mg containing mycophenolic acid is an effective immunosuppressant medication used for the prevention of organ rejection in kidney transplant recipients. By inhibiting lymphocyte proliferation and antibody production, mycophenolic acid helps to maintain the function of transplanted kidneys and improve the long-term outcomes of transplant recipients.

This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.

Customer reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Myfortic Tablet 180mg”